Welcure Drugs & Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
109.32 Cr.
|
P/BV
|
1.07
|
Book Value (Rs.)
|
9.12
|
52 Week High/Low (Rs.)
|
16/6
|
FV/ML
|
10/1
|
P/E(X)
|
50.41
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.19
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 30.05 | 24.55 | 0.00 | 0.00 | 0.00 |
Total Income From Operations | 30.05 | 24.55 | 0.00 | 0.00 | 0.00 |
Purchase of Traded Goods | 147.62 | 164.03 | 0.00 | 0.00 | 0.00 |
Increase/Decrease in Stocks | -122.53 | -143.52 | 0.00 | 0.00 | 0.00 |
Employees Cost | 0.36 | 0.15 | 0.06 | 0.03 | 0.03 |
Depreciation | 0.01 | 0.01 | 0.03 | 0.01 | 0.00 |
Other Expenses | 3.03 | 2.40 | 0.05 | 0.09 | 0.03 |
Total Expenses | 28.51 | 23.06 | 0.14 | 0.13 | 0.06 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 1.54 | 1.49 | -0.14 | -0.13 | -0.06 |
Other Income | 1.91 | 0.00 | 0.09 | 0.00 | 0.23 |
P/L Before Interest, Excpt. Items & Tax | 3.45 | 1.49 | -0.05 | -0.13 | 0.16 |
P/L Before Exceptional Items & Tax | 3.45 | 1.49 | -0.05 | -0.13 | 0.16 |
P/L Before Tax | 3.45 | 1.49 | -0.05 | -0.13 | 0.16 |
Tax | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
P/L After Tax from Ordinary Activities | 2.95 | 1.49 | -0.05 | -0.13 | 0.16 |
Net Profit/Loss For the Period | 2.95 | 1.49 | -0.05 | -0.13 | 0.16 |
| | | | | |
Equity Share Capital | 112.44 | 13.44 | 13.44 | 13.44 | 13.44 |
Reserves And Surplus | 0.00 | 0.00 | 0.00 | 0.00 | -11.92 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 0.26 | 0.13 | -0.03 | -0.01 | 0.12 |
Diluted EPS (Rs.) | 0.26 | 0.13 | (0.04) | -0.01 | 0.12 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 0.26 | 0.13 | -0.03 | -0.01 | 0.12 |
Diluted EPS (Rs.) | 0.00 | 0.13 | 0.00 | -0.01 | 0.00 |
| | | | | |
PBITOE Margin (%) | 5.13 | 6.08 | N.A | N.A | N.A |
PBTE Margin (%) | 11.49 | 6.08 | N.A | N.A | N.A |
PBT Margin (%) | 11.49 | 6.08 | N.A | N.A | N.A |
PAT Margin (%) | 9.82 | 6.08 | N.A | N.A | N.A |